1. An interactive web-based dashboard to track COVID-19 in real time;E Dong;The Lancet Infectious Diseases,2020
2. Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant;E. Mahase;The BMJ,2021
3. Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial | Janssen. [cited 26 Apr 2021]. Available: https://www.janssen.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints
4. Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization;P Wang;bioRxiv Prepr Serv Biol,2021
5. Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera;X Xie;bioRxiv,2021